surmount 5 tirzepatide SURMOUNT-5 Trial: vs Semaglutide in Obesity Management SURMOUNT-MAINTAIN: Drop Your Tirzepatide Dose?

Prediabetes is associated with an increased risk of cardiovascular disease

14.2 Obstructive Sleep Apnea Studies in Adults with Obesity SPL UNCLASSIFIED SECTION SPL UNCLASSIFIED SECTION Overview of Study 5 and Study 6 The efficacy of ZEPBOUND for moderate to severe obstructive sleep apnea (OSA) (apnea-hypopnea index [AHI] 15) in patients with obesity (BMI 30 kg/m 2 ) was evaluated in a master protocol clinical trial (NCT05412004) that included two randomized, double-blind, placebo-controlled trials (Study 5 and Study 6) of 52 weeks duration

Your creative team for digital magic show dedicated to corporate event

The choice is yours

AOD-9604 should be avoided or used only under close medical supervision in certain populations